Skip to content

Effect Of Nigdigdhikadi Kwatha And Ghritayavadi Dhuma In The Management Of COPD.

Efficacy of Nidigdhikadi Kwatha alone & in combination with Ghritayavadi Dhuma in the management of Tamaka shwasa w. s.r to Grade -I COPD, A double arm open -label comparative study. - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071114
Enrollment
60
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Sponsors

Ayurvedic And Unani Tibbia College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Symptomatological criteria - patients having history of respiratory signs and symptoms mentioned in modern texts such as chronic cough, increased sputum production, exertional dyspnea, wheezing, chest tightness, Recurrent lower respiratory tract infections with a history of exposure to risk factors (Host factors– Genetic factors, Tobacco smoke, Occupation, Indoor or outdoor pollution) 2 Spirometry criteria–FEV1 divided by FVC less than 0.7and FEV1 greater than equals to 80 percent 3 Patients willing to participate in trial

Exclusion criteria

Exclusion criteria: 1 Pregnant and lactating women Patients having respiratory complications like Cor-pulmonale, and diseases like Active Pulmonary TB, Pneumonia, Status Asthmaticus, Cystic fibrosis, Pleural effusion, Pneumothorax, Lung cancer and other systemic diseases like Severe anaemia, Renal failure, Cardiovascular disease. 2 Patients suffering from malignant and accelerated hypertension( 160 by 100 mm of Hg), coronary artery disease, uncontrolled diabetes(HbA1c greater than 8 percent). 3 Patient undergoing regular treatment for any other severe illness and also patient on prolonged corticosteroid use.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parameters like mMRC (Modified British Medical Research Council) Dyspnea scale , CAT (COPD assessment test) scale , GOLD criteria of spirometry , BODE index for Quality of life. Timepoint: Day1,Day 91

Secondary

MeasureTime frame
Overall improvement in quality of life.Timepoint: Day1,Day 91

Countries

India

Contacts

Public ContactDr Sujata Yadav

AYURVEDIC AND UNANI TIBBIA COLLEGE AND HOSPITAL

sujatakcdelhi@gmail.com9810571653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026